These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10452530)

  • 1. Oligonucleotide-peptide conjugates as potential antisense agents.
    Zubin EM; Romanova EA; Volkov EM; Tashlitsky VN; Korshunova GA; Shabarova ZA; Oretskaya TS
    FEBS Lett; 1999 Jul; 456(1):59-62. PubMed ID: 10452530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of oligonucleotide-peptide conjugates for biomedical and technological applications.
    Aviñó A; Grijalvo S; Pérez-Rentero S; Garibotti A; Terrazas M; Eritja R
    Methods Mol Biol; 2011; 751():223-38. PubMed ID: 21674334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stepwise synthesis of oligonucleotide-peptide conjugates containing guanidinium and lipophilic groups in their 3'-termini.
    Grijalvo S; Terrazas M; Aviñó A; Eritja R
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2144-7. PubMed ID: 20206515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Peptide-oligonucleotide conjugates by Diels-Alder cycloaddition in water.
    Marchán V; Grandas A
    Curr Protoc Nucleic Acid Chem; 2007 Dec; Chapter 4():Unit 4.32. PubMed ID: 18428978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total stepwise solid-phase synthesis of oligonucleotide-(3'-->N)-peptide conjugates.
    Stetsenko DA; Malakhov AD; Gait MJ
    Org Lett; 2002 Sep; 4(19):3259-62. PubMed ID: 12227763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of peptide-oligonucleotide conjugates using a heterobifunctional crosslinker.
    Williams BA; Chaput JC
    Curr Protoc Nucleic Acid Chem; 2010 Sep; Chapter 4():Unit4.41. PubMed ID: 20827717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of phosphorothioate oligonucleotide-peptide conjugates by solid phase fragment condensation.
    Diala I; Osada A; Maruoka S; Imanisi T; Murao S; Ato T; Ohba H; Fujii M
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6576-8. PubMed ID: 17942304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A concise method for the preparation of peptide and arginine-rich peptide-conjugated antisense oligonucleotide.
    Chen CP; Zhang LR; Peng YF; Wang XB; Wang SQ; Zhang LH
    Bioconjug Chem; 2003; 14(3):532-8. PubMed ID: 12757376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragment-based solid-phase assembly of oligonucleotide conjugates with peptide and polyethylene glycol ligands.
    Dirin M; Urban E; Noe CR; Winkler J
    Eur J Med Chem; 2016 Oct; 121():132-142. PubMed ID: 27236069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of antisense oligonucleotide-peptide conjugates with negative ionization electrospray mass spectrometry and liquid chromatography-mass spectrometry.
    Tengvall U; Auriola S; Antopolsky M; Azhayev A; Biegelman L
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):581-90. PubMed ID: 12899948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of high quality phosphorothioate oligonucleotides as antisense drugs. Use of I-linker in the elimination of 3'-terminal phosphorothioate monoesters.
    Ravikumar VT; Kumar RK; Capaldi DC; Cole DL
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1421-5. PubMed ID: 14565433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward high yield synthesis of peptide-oligonucleotide chimera through a disulfide bridge: a simplified method for oligonucleotide activation.
    Maurel F; Debart F; Cavelier F; Thierry AR; Lebleu B; Vasseur JJ; Vivès E
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5084-7. PubMed ID: 16168651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugates of oligonucleotides and analogues with cell penetrating peptides as gene silencing agents.
    Zatsepin TS; Turner JJ; Oretskaya TS; Gait MJ
    Curr Pharm Des; 2005; 11(28):3639-54. PubMed ID: 16305500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Native chemical ligation in the synthesis of internally modified oligonucleotide-peptide conjugates.
    Diezmann F; Eberhard H; Seitz O
    Biopolymers; 2010; 94(4):397-404. PubMed ID: 20593471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligonucleotides conjugated to short lysine chains.
    Winkler J; Urban E; Noe CR
    Bioconjug Chem; 2005; 16(4):1038-44. PubMed ID: 16029048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A convenient method for the synthesis of oligonucleotide-cationic peptide conjugates.
    Ferenc G; Kupihár Z; Kele Z; Kovács L
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):1059-61. PubMed ID: 16248092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antiviral activity of peptide-oligonucleotide conjugates prepared by using N alpha-(bromoacetyl)peptides.
    Arar K; Aubertin AM; Roche AC; Monsigny M; Mayer R
    Bioconjug Chem; 1995; 6(5):573-7. PubMed ID: 8974456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense Oligonucleotides Internally Labeled with Peptides Show Improved Target Recognition and Stability to Enzymatic Degradation.
    Taskova M; Madsen CS; Jensen KJ; Hansen LH; Vester B; Astakhova K
    Bioconjug Chem; 2017 Mar; 28(3):768-774. PubMed ID: 28292178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense inhibition of human telomerase by phosphorothioate oligonucleotide-peptide conjugates.
    Diala I; Murao S; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):679-80. PubMed ID: 18776562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Special Issue "Synthesis and Applications of Oligonucleotide Conjugates".
    Lönnberg H
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29027972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.